Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/32093
Title: Corrigendum: Fc engineered ACE2-Fc is a potent multifunctional agent targeting SARS-CoV2.
Austin Authors: Wines, Bruce D;Kurtovic, Liriye;Trist, Halina M;Esparon, Sandra;Lopez, Ester;Chappin, Klasina;Chan, Li-Jin;Mordant, Francesca L;Lee, Wen Shi;Gherardin, Nicholas A;Patel, Sheila K ;Hartley, Gemma E;Pymm, Phillip;Cooney, James P;Beeson, James G;Godfrey, Dale I;Burrell, Louise M ;van Zelm, Menno C;Wheatley, Adam K;Chung, Amy W;Tham, Wai-Hong;Subbarao, Kanta;Kent, Stephen J;Hogarth, P Mark
Affiliation: Immune therapies Laboratory, Burnet Institute, Melbourne, VIC, Australia.
Life Sciences, Burnet Institute, Melbourne, VIC, Australia.
Immune therapies Laboratory, Burnet Institute, Melbourne, VIC, Australia.
Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, VIC, Australia.
Infectious Diseases and Immune Defence Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, VIC, Australia.
Medicine (University of Melbourne)
Department of Immunology and Pathology, Central Clinical School, Monash University, Melbourne, VIC, Australia.
Infectious Diseases and Immune Defence Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
Life Sciences, Burnet Institute, Melbourne, VIC, Australia.
Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, VIC, Australia.
Department of Immunology and Pathology, Central Clinical School, Monash University, Melbourne, VIC, Australia.
Issue Date: 2022
Date: 2023
Publication information: Frontiers in Immunology 2022; 13
URI: https://ahro.austin.org.au/austinjspui/handle/1/32093
DOI: 10.3389/fimmu.2022.1122516
ORCID: 
Journal: Frontiers in Immunology
Start page: 1122516
PubMed URL: 36703991
ISSN: 1664-3224
Type: Journal Article
Subjects: ACE2-Fc
ADCC
COVID-19
SARS-CoV-2
antibody effector function
complement
coronavirus
neutralization
Appears in Collections:Journal articles

Show full item record

Page view(s)

42
checked on Jul 22, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.